FDA cites another Indian drugmaker; Amneal and Intrexon work on new API;

> Another Indian API maker, Canton Laboratories, has been issued an FDA warning letter for not doing analytical testing on the APIs that it manufacturers. Warning Letter

> Contract manufacturer Steripack Poland has been approved by authorities in that country to offer services to pharmaceutical clients. Report

> New Jersey-based generic drugmaker Amneal Pharmaceuticals has a new deal with Intrexon to develop an improved production process for a complex active pharmaceutical ingredient. Release

> The FDA is holding a webinar on key aspects of the Drug Supply Chain Security Act (Title II of the Drug Quality and Security Act) and FDA's implementation plan. Register

And Finally... Production of pharmaceuticals fell 13.9% in the U.K. in January, the largest monthly decline since 1968. Story